HPLC and LC-MS are frequently listed on analytical reports for peptide and other research materials. Because both methods can appear on the same Certificate of Analysis, it is easy to treat them as interchangeable. They are not.
HPLC and LC-MS can provide complementary information, but the meaning of a result depends on the exact method, detector, reference material and reporting approach used by the laboratory.
What is HPLC used for?
High-performance liquid chromatography (HPLC) separates components of a sample as they move through a chromatographic system. In research-material documentation, HPLC with UV or another detector is often used to examine a chromatographic profile and estimate relative purity under the stated method.
A purity value reported from HPLC is therefore method-dependent. The column, mobile phase, gradient, detector settings, integration rules and sample preparation can all affect what is separated and what is detected.
A dominant chromatographic peak can support a purity assessment, but it does not automatically establish the chemical identity of that peak. This is one reason why purity and identity should be reviewed as separate analytical questions.
What is LC-MS used for?
Liquid chromatography–mass spectrometry (LC-MS) combines chromatographic separation with mass spectrometric detection. Mass spectrometry measures ions according to their mass-to-charge characteristics and can provide evidence that a detected component is consistent with the expected molecular mass or related structural information under the reported method.
For synthetic peptides, mass spectrometry is commonly used as part of identity characterization. Published analytical literature also describes the use of chromatography and mass spectrometry together when characterizing peptide reference materials and impurities.
That still does not mean that an LC-MS result answers every quality question. A mass match does not, by itself, establish the exact amount in a vial, endotoxin status, microbial status, elemental impurities or batch linkage.
Why laboratories may use both methods
HPLC and LC-MS often answer different parts of the same documentation problem:
| Question | Typical analytical evidence |
| What chromatographic components are detected and what is their relative response? | HPLC or LC with an appropriate detector |
| Is the target component consistent with the expected molecular identity? | Mass spectrometry / LC-MS under an appropriate method |
| How much material is present? | A validated quantitative procedure appropriate to the material |
| Does the report apply to the lot being supplied? | Batch and lot traceability, not an analytical instrument result |
This is why a short statement such as “HPLC tested” or “LC-MS tested” is not enough on its own. A useful report should identify what was measured and how the laboratory interpreted the result.
What HPLC purity does not automatically prove
A chromatographic purity percentage should not be used as a substitute for unrelated analytical parameters. Unless separately tested and documented, an HPLC purity result does not establish:
- molecular identity,
- net peptide content or quantitative amount,
- endotoxin status,
- microbial or sterility status,
- heavy metals or elemental impurities, or
- that the report is linked to the seller’s current inventory lot.
What LC-MS identity evidence does not automatically prove
Likewise, evidence that a component is consistent with an expected mass does not mean the sample has a particular chromatographic purity, contains the declared amount, or has passed unrelated microbiological or elemental tests. Each claim should be supported by the relevant test.
Five questions to ask when reading an HPLC or LC-MS report
- What parameter is the laboratory reporting? Identity, relative purity, content and impurity characterization are different objectives.
- What method and detector were used? The result should be interpreted within the stated procedure.
- Is there a report, sample, batch or lot identifier? Analytical results need traceability.
- Are the numerical results accompanied by units or a clear reporting basis? A percentage or mass value should not be read without context.
- Can the tested sample be connected to the material being supplied? Analytical quality and inventory linkage are separate questions.
Why method validation matters
Analytical procedures are expected to be suitable for their intended purpose. The FDA’s final ICH Q2(R2) guidance describes general principles for analytical procedure validation, reinforcing a basic documentation principle: a result is meaningful only in relation to a defined analytical objective and procedure.
For additional scientific context, peer-reviewed work on synthetic peptide reference standards describes the use of multiple analytical techniques, including chromatography and mass spectrometry, to address different characteristics rather than relying on a single result.
Continue the documentation review
Read How to Read a COA for Research Materials, Purity vs Identity and the Research Material Documentation Checklist. Current documentation examples are listed on COA & Batch Verification.
Research documentation only: this article discusses analytical methods and laboratory documentation. It does not provide medical, dosing, treatment or administration guidance.